Archaea-inspired deoxyribonuclease I liposomes prevent multiple organ dysfunction in sepsis
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.02.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Xinze Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China; Wenzhou Key Laboratory of Emergency and …. Hauptthemen laut MEDLINE: Deoxyribonuclease I, Sepsis, Multiple Organ Failure. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Neutrophil extracellular traps (NETs) and circulating cell-free DNA (cfDNA) are pivotal in driving excessive inflammation and organ damage during sepsis, with their levels correlating positively with sepsis severity in both patients and murine models. Despite the ability of deoxyribonuclease I (DNase I) to degrade NETs and cfDNA, its short half-life and rapid degradation limit its therapeutic effectiveness. To address this challenge, we developed a methyl-branched liposome fused with a red blood cell membrane for the systemic delivery of DNase I (DNase I/Rm-Lipo). The efficacy of DNase I/Rm-Lipo was evaluated in the stimulated immune cells and septic model. The data confirmed that DNase I/Rm-Lipo efficiently removed excess NETs and cfDNA in activated neutrophils. Following injection, DNase I/Rm-Lipo exhibited an extended circulation time, effectively suppressing neutrophil activation and regulating macrophage polarization to mitigate inflammation and prevent organ dysfunction in septic mice. These findings highlight the therapeutic potential of DNase I/Rm-Lipo as a promising candidate for sepsis management by targeting the degradation of NETs and cfDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China; Wenzhou Key Laboratory of Emergency and Disaster Medicine, Wenzhou 325035, China.
- Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
- Central Laboratory, the Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui 323000, China; Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University…
- Department of Emergency, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China; Wenzhou Key Laboratory of Emergency and Disaster Medicine, Wenzhou 325035, China. Electronic address: lzhq@wmu…
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Wu, F., Yu, D., Su, X., Wang, K., Huang, Z., & Lu, Z. (2025). Archaea-inspired deoxyribonuclease I liposomes prevent multiple organ dysfunction in sepsis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.050
Vancouver
Li X, Wu F, Yu D, Su X, Wang K, Huang Z, et al. Archaea-inspired deoxyribonuclease I liposomes prevent multiple organ dysfunction in sepsis. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.050
BibTeX
@article{Li2025,
author = {Li, Xinze and Wu, Fan and Yu, Dedong and Su, Xiayi and Wang, Kaikai and Huang, Zhiwei and Lu, Zhongqiu},
title = {Archaea-inspired deoxyribonuclease I liposomes prevent multiple organ dysfunction in sepsis},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.02.050}
}
EUVIMED